Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all synonyms
Cow (Bovine) Polyclonal HIPK2 Primary Antibody for IHC, WB - ABIN2779735
Steinmann, Schulte, Beck, Chachra, Bujnicki, Klempnauer: v-Myc inhibits C/EBPbeta activity by preventing C/EBPbeta-induced phosphorylation of the co-activator p300. in Oncogene 2009
Show all 3 Pubmed References
Human Monoclonal HIPK2 Primary Antibody for ELISA, WB - ABIN565400
Esposito, Tornincasa, Chieffi, De Martino, Pierantoni, Fusco: High-mobility group A1 proteins regulate p53-mediated transcription of Bcl-2 gene. in Cancer research 2010
Human Monoclonal HIPK2 Primary Antibody for ICC, IF - ABIN2668288
Isono, Nemoto, Li, Takada, Suzuki, Katsuki, Nakagawara, Koseki: Overlapping roles for homeodomain-interacting protein kinases hipk1 and hipk2 in the mediation of cell growth in response to morphogenetic and genotoxic signals. in Molecular and cellular biology 2006
Human Polyclonal HIPK2 Primary Antibody for EIA - ABIN358542
Guha, Chaerkady, Marimuthu, Patterson, Kashyap, Harsha, Sato, Bader, Lash, Minna, Pandey, Varmus: Comparisons of tyrosine phosphorylated proteins in cells expressing lung cancer-specific alleles of EGFR and KRAS. in Proceedings of the National Academy of Sciences of the United States of America 2008
Show all 4 Pubmed References
Hipk2 promotes PP1c-mediated Dvl (show DVL2 Antibodies) dephosphorylation via its C-terminal domain and is essential Dvl (show DVL2 Antibodies) stability.
Immunoprecipitation and pulldown experiments identified DCAF7 (show DCAF7 Antibodies) as an adaptor for the association of the adenovirus E1A (show BCKDHA Antibodies) protein with DYRK1A (show DYRK1A Antibodies) and HIPK2
HIPK2 polymorphisms rs2058265, rs6464214, and rs7456421 may have a role in kidney stone disease in Chinese males
HIPK2 overexpression may be a potential prognostic marker for predicting prognoses and a high risk of recurrence, particularly in patients with HPV-positive Tonsillar squamous cell carcinomas.
Furthermore, our results suggest that modulation of either HIPK2 levels or activity could be exploited to impair NRF2 (show GABPA Antibodies)-mediated signalling in cancer cells, and thus sensitise them to chemotherapeutic drugs.
PARP1 (show PARP1 Antibodies) can modulate the tumor-suppressing function of HIPK2 by regulating the protein stability of HIPK2.
Data show that HIPK2-T566 phosphorylation contributes to UV-induced HIPK2 activity but it is dispensable for doxorubicin response.
In this study, we report that the kinase HIPK2 is responsible for facilitating the Fbw7 (show FBXW7 Antibodies)-dependent proteasomal degradation of Notch1 (show NOTCH1 Antibodies) by phosphorylating its intracellular domain (Notch1 (show NOTCH1 Antibodies)-IC) within the Cdc4 (show FBXW7 Antibodies) phosphodegron motif.
the migration and invasion of hepatocellular carcinoma cells were impaired by knockdown of histone deacetylase 5 (show HDAC5 Antibodies) or hypoxia-inducible factor-1alpha but rescued when eliminating homeodomain-interacting protein kinase-2 in hepatocellular carcinoma cells, which suggested the critical role of histone deacetylase 5 (show HDAC5 Antibodies)-homeodomain-interacting protein kinase-2-hypoxia-inducible factor-1alpha pathway in hypoxia-induced metastasis.
These results suggest that the HIPK2-phospho-Ser271 CREB (show CREB1 Antibodies) axis is a new arsenic-responsive CREB (show CREB1 Antibodies) activation mechanism in parallel with the PKA-phospho-Ser133 CREB (show CREB1 Antibodies) axis.
Results demonstrated that HIPK2 may function as a novel regulator to modulate hepatic stellate cells activation, potentially by inhibiting the TGF-beta1 (show TGFB1 Antibodies)/Smad3 (show SMAD3 Antibodies) signaling pathway.
reveal a previously unrecognized role of HIPK2 activation in ER-stress-mediated neurodegeneration and its potential role as a biomarker and therapeutic target for amyotrophic lateral sclerosis
Results indicate that Hipk2 exerts a relevant role in the survival of cerebellar Purkinje cells and that Hipk2 genetic ablation generates cerebellar dysfunction compatible with an ataxic-like phenotype.
HIPK2 is ubiquitinated upon heat shock.
Phosphorylation of KLF3 (show KLF3 Antibodies) and CtBP2 (show CTBP2 Antibodies) by HIPK2 strengthens the interaction between these two factors and increases transcriptional repression by KLF3 (show KLF3 Antibodies).
Homeodomain-interacting protein kinase 2, a novel autoimmune regulator (show AIRE Antibodies) interaction partner, modulates promiscuous gene expression in medullary thymic epithelial cells.
Hipk2 has an essential role in mouse white fat development
data identify Hipk2 as a novel regulator of C/EBPbeta (show CEBPB Antibodies) and implicate different protein kinases in the cooperation of p300 (show NOTCH1 Antibodies) with C/EBPbeta (show CEBPB Antibodies) and C/EBPalpha (show CEBPA Antibodies)
Data indicate a critical kinase HIPK2 function in cytokinesis and in the prevention of tetraploidization.
Hipk2 is a haploinsufficient tumor suppressor gene for mouse lymphoma development.
This gene encodes a conserved serine/threonine kinase that is a member of the homeodomain-interacting protein kinase family. The encoded protein interacts with homeodomain transcription factors and many other transcription factors such as p53, and can function as both a corepressor and a coactivator depending on the transcription factor and its subcellular localization. Multiple transcript variants encoding different isoforms have been found for this gene.
homeodomain interacting protein kinase 2
, serine/threonine protein kinase
, homeodomain-interacting protein kinase 2-like
, homeodomain-interacting protein kinase 2
, homeodomain-interacting protein kinase-2
, nuclear body-associated kinase 1
, sialophorin tail-associated nuclear serine/threonine-protein kinase
, Mx-interacting protein kinase PKM